Internal Medicine, Pulmonary Disease · Boston, MA
NPI
1174818363
Since 2011
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Washington St, #369
Boston, MA, 02111
Phone (617) 636-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
1,610 services
Medicare patients, 2024
441
Average age 73
Drug cost, 2024
$2.0M
2,979 prescriptions
Company payments, 2025
$58.97
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maureen R Dziura was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 384 times for 180 patients. In total Maureen R Dziura billed 1,610 services in 33 codes, and Medicare paid $87K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 384 | 180 | $13.36 | $5,130 |
| 99214 Office E&M - Established | Office | 307 | 157 | $105.15 | $32K |
| 94060 Pulmonary Function Testing | Facility | 178 | 177 | $7.67 | $1,365 |
| 94729 Pulmonary Function Testing | Facility | 174 | 173 | $6.67 | $1,161 |
| 94727 Pulmonary Function Testing | Facility | 174 | 173 | $8.91 | $1,551 |
| 99291 Critical Care E&M | Facility | 115 | 42 | $163.29 | $19K |
| 99215 Office E&M - Established | Office | 64 | 43 | $156.04 | $9,987 |
| 99204 Office E&M - New | Office | 38 | 38 | $127.13 | $4,831 |
| 99233 Hospital E&M - Subsequent | Facility | 28 | 19 | $98.83 | $2,767 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 22 | 21 | $13.82 | $304 |
| 99406 Behavioral Health Services | Office | 20 | 16 | $15.71 | $314 |
| 99214 Office E&M - Established | Facility | 15 | 15 | $70.46 | $1,057 |
| 31624 Bronchoscopy | Facility | 13 | 13 | $63.30 | $823 |
By year: 2022 $65K for 873 services; 2023 $77K for 1,256 services; 2024 $87K for 1,610 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maureen R Dziura prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 469 prescriptions and refills. In total Maureen R Dziura wrote 2,979 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 469 | 544 | 81 | $346K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 283 | 348 | 95 | $9,154 |
| Montelukast Sodium Generic | 279 | 581 | 84 | $4,153 |
| Prednisone Generic | 232 | 255 | 93 | $1,095 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 227 | 277 | 60 | $166K |
| Azelastine Hcl Generic | 146 | 296 | 55 | $3,864 |
| Azithromycin Generic | 138 | 140 | 53 | $795 |
| Tezspire Tezepelumab-Ekko | 132 | 132 | 16 | $569K |
| Spiriva Respimat Tiotropium Bromide | 126 | 142 | 30 | $73K |
| Advair Hfa Fluticasone Propion/Salmeterol | 82 | 92 | 17 | $38K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 63 | 69 | 14 | $32K |
| Fluticasone Propionate Generic | 60 | 116 | 19 | $819 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 57 | 78 | 20 | $12K |
| Ventolin Hfa Albuterol Sulfate | 57 | 62 | 16 | $3,632 |
| Roflumilast Generic | 45 | 45 | Under 11 | $1,723 |
Brand drugs: 1,745 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maureen R Dziura $58.97 ($58.97 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $29.96.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29.96 |
| Grifols USA, LLC | 1 | $29.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.